NCT06619548

Brief Summary

The aim of this randomized controlled cross-over trial is to explore the efficacy of auricular magnet in treating childhood anorexia. Participants will be allocated to two groups, labeled as Group A and Group B. Prior to the commencement of the trial, parents or guardians of the participants are required to fill out basic information for their children, including age, gender, height, weight, etc., and to complete the Preschooler's Eating Behavior Scale questionnaire. Over the initial 7-day period, participants of Group A receive auricular magnet therapy while participants of Group B undergo placebo magnetic auricular therapy. This is followed by a 14-day washout period to eliminate any lingering effects from the initial treatment. In the second phase, the treatments are swapped between the two groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

September 27, 2024

Last Update Submit

September 27, 2024

Conditions

Keywords

anorexia in childrentraditional Chinese medicineauricular pointclinical trial

Outcome Measures

Primary Outcomes (1)

  • Eating behavior change

    The eating behavior is evaluated by the Preschooler's Eating Behavior Scale questionnaire.

    0, 7, 21, 28 days

Secondary Outcomes (1)

  • Body Mass Index (BMI) change

    0, 7, 21, 28 days

Study Arms (2)

Group A

EXPERIMENTAL

The participants will have auricular magnets with a strength of 1800 Gauss applied to specific acupoints in the first treatment phase. This is followed by a 14-day washout period. In the second treatment phase, the participants will have auricular magnets with no magnetic strength applied to the same acupoints.

Other: Auricular magnet with a magnetic strength of 1800 GaussOther: Auricular magnet with no magnetic strength

Group B

PLACEBO COMPARATOR

The participants will have auricular magnets with no magnetic strength applied to specific acupoints in the first treatment phase. This is followed by a 14-day washout period. In the second treatment phase, the participants will have auricular magnets with a strength of 1800 Gauss applied to the same acupoints.

Other: Auricular magnet with a magnetic strength of 1800 GaussOther: Auricular magnet with no magnetic strength

Interventions

Auricular magnets with a magnetic strength of 1800 Gauss are used as the experimental group.

Group AGroup B

Auricular magnets with no magnetic strength are used as placebo control.

Group AGroup B

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The pediatric patient has one or more of the following symptoms (at least once a week and lasting for at least two months):
  • Postprandial fullness
  • Early satiety
  • Epigastric pain
  • Epigastric burning sensation or has a weight below the 15th percentile for age and sex for at least two months.
  • No prokinetic or appetite-stimulating Western medications or spleen and stomach-strengthening Chinese medications have been used within the past two weeks.

You may not qualify if:

  • Congenital abnormalities of the digestive tract, cancer, and other major illnesses, or unwillingness to cooperate with testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taiwan

RECRUITING

Study Officials

  • Hung-Rong Yen, M.D., Ph.D.

    China Medical University, China

    STUDY CHAIR

Central Study Contacts

Hung-Rong Yen, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Department of Integration of Traditional Chinese-Western Medicine

Study Record Dates

First Submitted

September 27, 2024

First Posted

October 1, 2024

Study Start

October 1, 2024

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

October 1, 2024

Record last verified: 2024-09

Locations